Inhalers Segment is expected to be the fastest growing during the forecast period for MEA Medical Polyoxymethylene Market.

According to a new market research study on “MEA Medical Polyoxymethylene Market to 2028 – COVID-19 Impact and Analysis and Forecast by: Application,” is expected to reach US$ 5308.95 thousand by 2028 from US$ 4320.02 thousand in 2020. The market is estimated to grow at a CAGR of 2.6% from 2020 to 2028. The report provides trends prevailing in the MEA medical polyoxymethylene market along with the drivers and restraints pertaining to the market growth. Emergence of applications in tissue engineering is the major factor driving the growth of the MEA medical polyoxymethylene market. However, issues associated with the rigid regulations on use of thermoplastics and competition from traditional materials hinder the growth of MEA medical polyoxymethylene market.

The MEA medical polyoxymethylene market is segmented into application, and country. On the basis of application, the MEA medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.

Saudi Arabia has the highest number of COVID-19 cases in the Middle East and Africa, followed by Turkey and UAE, among others. The UAE was the first country in the Middle East and Africa to report a confirmed case of COVID-19. The pandemic has affected economies and industries in various countries across MEA region due to lockdowns, travel bans, and business shutdowns. Chemical and materials is one of the major industries suffering serious disruptions in the form of supply chain breaks and production plants shutdowns. The shutdown of various manufacturing plants and factories in MEA region has hampered the global supply chain as well as manufacturing processes, delivery schedules, and goods sales. Various companies have already announced possible delays in product deliveries and projected the slump in future sales of their products. In addition, global travel bans imposed by MEA countries are affecting the business collaboration and partnership opportunities. These factors are making the conditions conducive for the growth of the food & beverages industry, alongside restraining the growth of other markets related to this industry. Therefore, the MEA medical polyoxymethylene market is facing difficulties to grow due to shortfall in production and insufficiency of transportation facilities.

BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Korea Engineering Plastics Co., Ltd.; and Mitsubishi Chemical Corporation are among the leading companies in the MEA medical polyoxymethylene market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Polyplastics Group expanded its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON PM27S01N, offers reduced wall thickness, miniaturization, and lower weight for various medical devices that are becoming increasingly complicated and highly functional.

The Report Segments the MEA Medical Polyoxymethylene Market as Follows:

 MEA Medical Polyoxymethylene Market – By Application

• Dialysis Machine
• Handles for Surgical Instruments
• Inhalers
• Insulin Pen
• Others

MEA Medical Polyoxymethylene Market – By Country

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com